Remove Capital Raising Remove Medical Remove Private Equity
article thumbnail

Recap: 2023 Midwest M&A/Private Equity Forum

Focus Investment Banking

The 6th annual Midwest M&A/Private Equity Forum sponsored by the Thomson Reuters Institute was held in early December in Columbus, Ohio, and for your humble correspondent, this was not only my second time as one of the participants, but my first time as a moderator of a panel! More on that later.

article thumbnail

The Sky Definitely Is Not Falling…At Least Not Yet

Sica Fletcher

Update on Private Equity and Insurance Brokerages In our ,, previous article , we reported that the COVID-19 pandemic had not diminished the pace of mergers and acquisitions transactions we are seeing in the insurance agency and brokerage sector. These firms remain “on the clock” to deploy their capital.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FOCUS Investment Banking Welcomes New Managing Directors, Expanding Southeast and Midwest Presence

Focus Investment Banking

His work includes business sales and capital raises for middle-market companies as well as buy-side services for acquirers seeking middle-market companies. He has also spoken before the Thomson Reuters Midwestern M&A/Private Equity Forum, J.P. commented Rick Thomas, FOCUS Investment Banking CEO.

article thumbnail

Biotech Hedge Funds: A Match Made in Heaven

Mergers and Inquisitions

In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. But in biotech, companies valuations often remain close to their total capital raised until much later in the process (i.e., or Ph.D.),

Funds 64